CLOXOBET CREAM clobetasol propionate 0.05% w/w cream tube Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cloxobet cream clobetasol propionate 0.05% w/w cream tube

douglas pharmaceuticals australia pty ltd - clobetasol propionate, quantity: 0.5 mg/g - cream - excipient ingredients: propylene glycol; sodium citrate; citric acid monohydrate; chlorocresol; glyceryl monostearate; peg-100 stearate; white beeswax; purified water; cetostearyl alcohol - short-term treatment of resistant or severe inflammatory and pruritic manifestations of steroid responsive dermatoses, including psoriasis (excluding widespread plaque psoriasis), recalcitrant dermatoses, lichen sclerosus/planus and discoid lupus erythematosus in adults.

CLOXOBET OINTMENT clobetasol propionate 0.05% w/w ointment tube Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cloxobet ointment clobetasol propionate 0.05% w/w ointment tube

douglas pharmaceuticals australia pty ltd - clobetasol propionate, quantity: 0.5 mg/g - ointment - excipient ingredients: sorbitan sesquioleate; propylene glycol; white soft paraffin - short-term treatment of resistant or severe inflammatory and pruritic manifestations of steroid responsive dermatoses, including psoriasis (excluding widespread plaque psoriasis), recalcitrant dermatoses, lichen sclerosus/planus and discoid lupus erythematosus in adults.

DPL-CLOBETASOL CREAM clobetasol propionate 0.05% w/w cream tube Ástralía - enska - Department of Health (Therapeutic Goods Administration)

dpl-clobetasol cream clobetasol propionate 0.05% w/w cream tube

douglas pharmaceuticals australia pty ltd - clobetasol propionate, quantity: 0.5 mg/g - cream - excipient ingredients: propylene glycol; sodium citrate; citric acid monohydrate; chlorocresol; glyceryl monostearate; peg-100 stearate; white beeswax; purified water; cetostearyl alcohol - short-term treatment of resistant or severe inflammatory and pruritic manifestations of steroid responsive dermatoses, including psoriasis (excluding widespread plaque psoriasis), recalcitrant dermatoses, lichen sclerosus/planus and discoid lupus erythematosus in adults.

DPL-CLOBETASOL OINTMENT clobetasol propionate 0.05% w/w ointment tube Ástralía - enska - Department of Health (Therapeutic Goods Administration)

dpl-clobetasol ointment clobetasol propionate 0.05% w/w ointment tube

douglas pharmaceuticals australia pty ltd - clobetasol propionate, quantity: 0.5 mg/g - ointment - excipient ingredients: sorbitan sesquioleate; propylene glycol; white soft paraffin - short-term treatment of resistant or severe inflammatory and pruritic manifestations of steroid responsive dermatoses, including psoriasis (excluding widespread plaque psoriasis), recalcitrant dermatoses, lichen sclerosus/planus and discoid lupus erythematosus in adults.

XOBET CREAM clobetasol propionate 0.05% w/w cream tube Ástralía - enska - Department of Health (Therapeutic Goods Administration)

xobet cream clobetasol propionate 0.05% w/w cream tube

douglas pharmaceuticals australia pty ltd - clobetasol propionate, quantity: 0.5 mg/g - cream - excipient ingredients: propylene glycol; sodium citrate; citric acid monohydrate; chlorocresol; glyceryl monostearate; peg-100 stearate; white beeswax; purified water; cetostearyl alcohol - short-term treatment of resistant or severe inflammatory and pruritic manifestations of steroid responsive dermatoses, including psoriasis (excluding widespread plaque psoriasis), recalcitrant dermatoses, lichen sclerosus/planus and discoid lupus erythematosus in adults.

XOBET OINTMENT clobetasol propionate 0.05% w/w ointment tube Ástralía - enska - Department of Health (Therapeutic Goods Administration)

xobet ointment clobetasol propionate 0.05% w/w ointment tube

douglas pharmaceuticals australia pty ltd - clobetasol propionate, quantity: 0.5 mg/g - ointment - excipient ingredients: sorbitan sesquioleate; propylene glycol; white soft paraffin - short-term treatment of resistant or severe inflammatory and pruritic manifestations of steroid responsive dermatoses, including psoriasis (excluding widespread plaque psoriasis), recalcitrant dermatoses, lichen sclerosus/planus and discoid lupus erythematosus in adults.

ORALJECT P-BUTAZONE PASTE ORAL ANTI-INFLAMMATORY ANALGESIC AGENT FOR HORSES Ástralía - enska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oralject p-butazone paste oral anti-inflammatory analgesic agent for horses

virbac (australia) pty ltd - phenylbutazone - oral paste - phenylbutazone analgesic active 1.0 g/5ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - anti-inflammatory agent | antipyretic | bone soreness | bruising | bursitis | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle soreness | osteoarthritis | platelet activity | rheumatism | sprains | strains | tendon sprains | traumatic swelling